Hepatitis

Hepatitis
Hepatitis
• Inflammation of the liver • Types of viral

• Causes hepatitis
• Viral (most common): • A [HAV]
acute or chronic • B [HBV]
• Drugs (alcohol), some • C [HCV]
herbs • D [HDV]
• Chemicals [Table 39-6] • E [HEV]
• Autoimmune diseases • Non A-E
• Metabolic abnormalities
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
TOXIC & DRUG-INDUCED
HEPATITIS
• Exposure to hepatotoxins
[industrial toxins, alcohol, drugs]
• Secondary infection during the
course of infections w/other viruses;
i.e Epstein-Barr, herpes simplex,
VZV, cytomegalovirus
Hepatitis A Virus (HAV)
• Ranges from mild to acute liver failure

• Not chronic
• Incidence decreased with vaccination
• RNA virus transmitted via fecal-oral
route
• Person-person contact: oral-anal sexual
• Contaminated food or drinking water
• Survives on human hands
• Destroyed by chlorine bleach & high
temps
Serologic Events in HAV Infection

Hepatitis B Virus (HBV)
• Acute or chronic disease

• Incidence decreased with vaccination
• DNA virus transmitted
• Perinatally
• Percutaneously: needle sticks, sharps
• Via mucosal exposure to infectious blood,
blood products, or other body fluids
• Carriers: infect others even if not sick & no
obvious signs of Hep B
• Chronic: high risk for liver cancer and cirrhosis
Hepatitis B Virus (HBV)
• At-risk populations
• Men who have sex with men
• Household contact of chronically
infected
• Patients undergoing hemodialysis
• Health care and public safety workers
• Transplant recipients
Serologic Events in HBV Infection

Hepatitis C Virus (HCV)
• Acute: asymptomatic
• Chronic: liver damage
• Not transmitted by
• RNA virus transmitted casual contact or
percutaneously
• IV drug use: highest incidence
intimate household
• High-risk sexual behaviors: contact
multiple partners
• Occupational exposure • Should not share
• Dialysis razors,
• Perinatal exposure
• Blood transfusions before toothbrushes,
1992 pierced earrings
• Sharing intranasal cocaine
paraphernalia • NO vaccine at
present
Hepatitis D Virus (HDV)
• Also called delta virus
• Defective single-stranded RNA virus
• Cannot survive on its own
• Requires HBV to replicate
• Transmitted
parenterally/percutaneously
• IVDA; high risk sexual contact w/HDV
infected person
• No vaccine
Hepatitis E Virus (HEV)
• RNA virus
• Transmitted via fecal-oral route
• Most common mode of transmission:
drinking contaminated water/food
• Self-limiting; resolves on own
• Incubates 15-64 days
Pathophysiology
• Acute infection
• Liver damage: lysis of infected cells
• Cholestasis
• Liver cells can regenerate in normal
form after resolution of infection
• Chronic infection can cause fibrosis
and progress to cirrhosis {Hep B/C]
Pathophysiology
• Antigen-antibody complexes
activate complement system
• Systemic manifestations
• Rash • Malaise
• Angioedema • Cryoglobulinemia
• Arthritis • Glomerulonephritis
• Fever • Vasculitis
Clinical Manifestations
• Classified as acute and chronic
phases
• Many patients: asymptomatic
• Symptoms intermittent or ongoing
• Malaise
• Fatigue
• Myalgias/arthalgias
• Hepatomegaly
• Acute phase
• Maximal infectivity; lasts 1–4 months
• Symptoms during incubation
• Malaise • ↓ Sense of smell
• Anorexia • Headache
• Weight loss • Low-grade fever
• Fatigue • Arthralgias
• Nausea/vomiting • Skin rashes
• Abdominal discomfort: RUQ
• Distaste for cigarettes
• Acute phase
• Physical examination findings
• Hepatomegaly
• Lymphadenopathy
• Splenomegaly
• Icteric (jaundice) or anicteric
• If icteric, patient can also have
• Dark urine
• Light or clay-colored stools
• Pruritus
• Convalescent phase
• Begins as jaundice is disappearing
• Lasts weeks to months
• Major complaints
• Malaise
• Easy fatigability
• Hepatomegaly persists
• Splenomegaly subsides
Recovery
• Homologous immunity to HAV or
HBV
• Patient can be reinfected with other
types of viral hepatitis, as well as
different strains of HCV
• Most patients recover completely
with no complications
Complications
• Acute liver failure: Fulminant
Hepatitis: fatal
• Chronic hepatitis
• Some HBV and majority of HCV
infections
• Cirrhosis
• Hepatocellular carcinoma
Diagnostic Studies
• Specific antigen and/or antibody for
each type of viral hepatitis
• Anti-HAV IgM , anti-HAV IgG
• HBsAg, anti-HBs, HBeAg, anti-Hbe,
anti-HBc IgM, anti-HBc IgG, HBV DNA
quantitation
• Anti-HCV, HCV quantitation
• Anti-HDV, HDV Ag
• None currently for HEV
Diagnostic Studies
• Liver function tests
• Viral genotype testing
• HBV
• HCV
• Physical assessment findings
• Liver biopsy
• FibroScan
• FibroSure (FibroTest)
Collaborative Care
• Acute and chronic
• Well-balanced diet
• Increased calorie
• Low fat if not tolerated
• Vitamin supplements
• Rest: degree varies with severity
• Avoid alcohol intake and drugs
detoxified by the liver
• Notification of possible contacts
Collaborative Care: Drug Therapy
• Acute hepatitis A: no specific
• Acute hepatitis B: only if severe
• Acute hepatitis C
• Pegylated interferon to reduce
progression to chronic infection
• Support therapy
• Antiemetics
Collaborative Care
Chronic Hepatitis B
• To ↓ viral load , liver enzyme levels,
and rate of disease progression
• Prevent cirrhosis, hepatic failure,
and cancer
• Pegylated interferon
• Nucleoside and nucleotide analogs
• SCREENING: liver CA: screen every
6-12 months
Drug Therapy
Chronic Hepatitis B
• Interferon
• Multiple effects on viral replication
• Two forms: standard and pegylated
• Must be administered subcutaneously
• Varied response to treatment
• Side effects
• Flu-like symptoms, depression,
irritability, insomnia, neutropenia,
thrombocytopenia
Drug Therapy
Chronic Hepatitis B
• Nucleoside/nucleotide analogs
• Decrease viral replication by inhibiting
normal DNA synthesis
• Lamivudine (Epivir)
• Adefovir (Hepsera)
• Entecavir (Baraclude)
• Telbivudine (Tyzeka)
• Tenofovir (Viread)
• Long-term treatment
Drug Therapy
Chronic Hepatitis C
• Individualized treatment regimens
• Pegylated a-inteferon: SubQ
• Pegylated α-interferon with ribavirin
(Rebetol, Copegus)
• Ribavirin: teratogenic
• Take as prescribed
• Protease inhibitors for genotype 1
• Telaprevir (Incivek)
• Boceprevir (Victrelis)
Collaborative Care
• Health promotion: hepatitis A
• General measures
• Vaccination best protection
• All children at 1 year of age should receive
vaccine
• Adults at risk
• Infection control measures; isolation not
required
• Post-exposure prophylaxis with vaccine and
immune globulin (IG)-temporary passive
immunity
Collaborative Care
• Health promotion: hepatitis B
• General measures
• Immunization
• Recombivax HB, Engerix-B
• Series of three IM injections
• All children and at-risk adults
• Postexposure prophylaxis: vaccine and
hepatitis B immune globulin (HBIG)
Collaborative Care
• Health promotion: hepatitis C
• No vaccine to prevent HCV
• General measures to prevent HCV
transmission
• Screen all persons born between 1945
and 1965
• No postexposure prophylaxis; baseline
and follow-up testing
Nursing Implementation
• Acute care
• Assess for jaundice
• Comfort measures
• Adequate nutrition
• Small, frequent meals
• Measures to stimulate appetite
• Carbonated beverages
• Adequate fluid intake
• Acute care
• Physical rest
• Psychologic and emotional rest
• Diversional activities
• Ambulatory and home care
• Dietary teaching
• Activity restrictions
• Teach how to prevent transmission
• What to report
• Assessment for complications
• Regular follow-up for at least 1 year after diagnosis
• No alcohol
• Medication education
• How to administer interferon
• Side effects
• No blood donation by HBsAg- or HCV-positive
patients Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
• Ambulatory and home care
• Regular follow-up for at least 1 year
after diagnosis
• No alcohol
• Medication education
• How to administer interferon
• Side effects
• No blood donation by HBsAg- or HCV-
positive patients
Evaluation
• Expected outcomes
• Adequate nutritional intake
• Increased tolerance of activity
• Performing daily activities with
scheduled rest periods
• Ability to explain methods of
transmission and methods of
preventing transmission
Review
• Chart 58B: Best Practice for Patient
Safety & Quality Care
• Patient and Family Education:
Health Practices to Prevent Viral
Hepatitis
• DRUG Therapy for Chronic B/C
• Preparing for Self-Management: 58-
5: Viral Hepatitis

Hepatitis

Uploaded by

Copyright:

Available Formats

Hepatitis

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Hepatitis

Uploaded by

Copyright:

Available Formats

What are the main causes of hepatitis?

What are the different types of viral hepatitis?

Hepatitis

• Inflammation of the liver • Types of viral

• Ranges from mild to acute liver failure

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

• Acute or chronic disease

Copyright © 2014 by Mosby, an imprint of Elsevier Inc.

You might also like